CB2 Insights Inc. (CSE:CBII,Forum) announced on Thursday that MyAccess Clinics (a subsidiary of Althea Group Holdings Ltd (ASX:AGH)) has selected the Company’s Electronic Data Capture software to manage its medical cannabis patient data in the UK.
For more on this, click here.
CB2 recently appointeda Medical Director in Colombia on and intends to enter that market with a cannabis research focus.
FULL DISCLOSURE: CB2 Insights Inc. is a client of Stockhouse Publishing.